Search research articles
Contact Us
Filters
Showing results (211-220 of 304) with videos related to
Page
of 31
Sort By:
Clinical and Translational Science
|
December 19, 2020
Effects of Rovalpituzumab Tesirine on Ventricular Repolarization in Patients With Small-Cell Lung Cancer
Jonathan W Goldman, Minal Barve, Jyoti D Patel, et al.
Science (New York, N.Y.)
|
November 7, 2015
Pharmacological chaperone for α-crystallin partially restores transparency in cataract models
Leah N Makley, Kathryn A McMenimen, Brian T DeVree, et al.
JCI Insight
|
September 21, 2023
The XIST lncRNA is a sex-specific reservoir of TLR7 ligands in SLE
Jonathan D Crawford, Hong Wang, Daniela Trejo-Zambrano, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 6, 2026
Genomic Profiling of Epidermal Growth Factor Receptor Mutation-Positive Non-Small Cell Lung Cancer Post-Progression on First-Line Osimertinib: Phase II ORCHARD Study
Helena A Yu, Kwan Ho Tang, Aleksandra A Markovets, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 28, 2014
An open-label phase Ib dose-escalation study of TRC105 (anti-endoglin antibody) with bevacizumab in patients with advanced cancer
Michael S Gordon, Francisco Robert, Daniela Matei, et al.
Nature Communications
|
March 21, 2023
Affinity maturation generates pathogenic antibodies with dual reactivity to DNase1L3 and dsDNA in systemic lupus erythematosus
Eduardo Gomez-Bañuelos, Yikai Yu, Jessica Li, et al.
Ebiomedicine
|
December 18, 2021
Deconvoluting virome-wide antibody epitope reactivity profiles
Daniel R Monaco, Sanjay V Kottapalli, Florian P Breitwieser, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 26, 2022
Phase Ib Study of Telisotuzumab Vedotin in Combination With Erlotinib in Patients With c-Met Protein-Expressing Non-Small-Cell Lung Cancer
D Ross Camidge, Fabrice Barlesi, Jonathan W Goldman, et al.
Frontiers in Oncology
|
August 9, 2018
<i>nab</i>-Paclitaxel-Based Therapy in Underserved Patient Populations: The ABOUND.70+ Study in Elderly Patients With Advanced NSCLC
Corey J Langer, Edward S Kim, Eric C Anderson, et al.
NPJ Precision Oncology
|
June 26, 2026
Redefining therapeutic horizons in thymic epithelial tumors: precision, combinations, and emerging biology
Jennifer A Marks, Rohan Maniar, Kavitha J Ramchandran, et al.
Page
of 31
Search research articles
Search
Showing results (211-220 of 304) with videos related to
Sort By:
Page
of 31
Clinical and Translational Science
|
December 19, 2020
Effects of Rovalpituzumab Tesirine on Ventricular Repolarization in Patients With Small-Cell Lung Cancer
Jonathan W Goldman, Minal Barve, Jyoti D Patel, et al.
Science (New York, N.Y.)
|
November 7, 2015
Pharmacological chaperone for α-crystallin partially restores transparency in cataract models
Leah N Makley, Kathryn A McMenimen, Brian T DeVree, et al.
JCI Insight
|
September 21, 2023
The XIST lncRNA is a sex-specific reservoir of TLR7 ligands in SLE
Jonathan D Crawford, Hong Wang, Daniela Trejo-Zambrano, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 6, 2026
Genomic Profiling of Epidermal Growth Factor Receptor Mutation-Positive Non-Small Cell Lung Cancer Post-Progression on First-Line Osimertinib: Phase II ORCHARD Study
Helena A Yu, Kwan Ho Tang, Aleksandra A Markovets, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 28, 2014
An open-label phase Ib dose-escalation study of TRC105 (anti-endoglin antibody) with bevacizumab in patients with advanced cancer
Michael S Gordon, Francisco Robert, Daniela Matei, et al.
Nature Communications
|
March 21, 2023
Affinity maturation generates pathogenic antibodies with dual reactivity to DNase1L3 and dsDNA in systemic lupus erythematosus
Eduardo Gomez-Bañuelos, Yikai Yu, Jessica Li, et al.
Ebiomedicine
|
December 18, 2021
Deconvoluting virome-wide antibody epitope reactivity profiles
Daniel R Monaco, Sanjay V Kottapalli, Florian P Breitwieser, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 26, 2022
Phase Ib Study of Telisotuzumab Vedotin in Combination With Erlotinib in Patients With c-Met Protein-Expressing Non-Small-Cell Lung Cancer
D Ross Camidge, Fabrice Barlesi, Jonathan W Goldman, et al.
Frontiers in Oncology
|
August 9, 2018
<i>nab</i>-Paclitaxel-Based Therapy in Underserved Patient Populations: The ABOUND.70+ Study in Elderly Patients With Advanced NSCLC
Corey J Langer, Edward S Kim, Eric C Anderson, et al.
NPJ Precision Oncology
|
June 26, 2026
Redefining therapeutic horizons in thymic epithelial tumors: precision, combinations, and emerging biology
Jennifer A Marks, Rohan Maniar, Kavitha J Ramchandran, et al.
Page
of 31